Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan for Metabolic Problems in Schizophrenia
NCT00981526Phase 4Completed
- Sponsor
- University of Massachusetts
- Start
- Mar 2009
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in insulin resistance (IR) and hypertriglyceridemia comparing Telmisartan with Placebo (2 arms). Primary endpoints: Insulin Resistance (HOMA-IR) at 12 weeks and Fasting Triglycerides at 12 weeks. Started Mar 2009; status: completed.
02
Drugs
telmisartan
03
Conditions
insulin resistance (IR)hypertriglyceridemia
Beyond the preview
Go deeper on NCT00981526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00981526.